Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimating optimal therapeutic drug levels of anti-tuberculosis medications based on treatment safety and effectiveness.
Amorim G, Haas DW, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Staats C, Hachey B, Turner M, Andrade BB, Rolla VC, Sterling TR; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil network. Amorim G, et al. Among authors: kritski al. medRxiv [Preprint]. 2024 Aug 31:2024.08.30.24312723. doi: 10.1101/2024.08.30.24312723. medRxiv. 2024. PMID: 39252925 Free PMC article. Preprint.
Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.
Amorim G, Jaworski J, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Turner M, Andrade BB, Velez Edwards DR, Santos AR, Rolla VC, Sterling TR, Haas DW; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil network. Amorim G, et al. Among authors: kritski al. medRxiv [Preprint]. 2023 Sep 1:2023.08.30.23294860. doi: 10.1101/2023.08.30.23294860. medRxiv. 2023. Update in: Pharmacogenet Genomics. 2024 Oct 15. doi: 10.1097/FPC.0000000000000552 PMID: 37693472 Free PMC article. Updated. Preprint.
Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in Brazil.
Mendelsohn SC, Andrade BB, Mbandi SK, Andrade AMS, Muwanga VM, Figueiredo MC, Erasmus M, Rolla VC, Thami PK, Cordeiro-Santos M, Penn-Nicholson A, Kritski AL, Hatherill M, Sterling TR, Scriba TJ; RePORT–South Africa and RePORT–Brazil Consortia. Mendelsohn SC, et al. Among authors: kritski al. J Infect Dis. 2024 Dec 16;230(6):e1355-e1365. doi: 10.1093/infdis/jiae237. J Infect Dis. 2024. PMID: 38709708 Free PMC article.
Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in Brazil.
Piekos JA, Amorim G, Ridolfi F, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Andrade BB, Santos AR, Haas DW, Sterling TR, Rolla VC, Edwards DRV; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil consortium. Piekos JA, et al. Among authors: kritski al. medRxiv [Preprint]. 2024 Aug 30:2024.08.29.24312595. doi: 10.1101/2024.08.29.24312595. medRxiv. 2024. PMID: 39252933 Free PMC article. Preprint.
Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.
Amorim G, Jaworski J, Yang J, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Turner M, Andrade BB, Velez Edwards DR, Santos AR, Rolla VC, Sterling TR, Haas DW; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil network. Amorim G, et al. Among authors: kritski al. Pharmacogenet Genomics. 2025 Feb 1;35(2):55-64. doi: 10.1097/FPC.0000000000000552. Epub 2024 Oct 15. Pharmacogenet Genomics. 2025. PMID: 39470346
Three months of rifapentine and isoniazid for latent tuberculosis infection.
Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR Jr, Chaisson RE; TB Trials Consortium PREVENT TB Study Team. Sterling TR, et al. N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875. N Engl J Med. 2011. PMID: 22150035 Free article. Clinical Trial.
Retreatment and Anti-tuberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study.
Barreto-Duarte B, Villalva-Serra K, Miguez-Pinto JP, Araújo-Pereira M, Campos VMS, Rosier G, Nogueira BMF, Queiroz ATL, Rolla VC, Cordeiro-Santos M, Kritski AL, Martinez L, Rebeiro PF, Sterling TR, Rodrigues MM, Andrade BB. Barreto-Duarte B, et al. Among authors: kritski al. Open Forum Infect Dis. 2024 Jul 18;11(8):ofae416. doi: 10.1093/ofid/ofae416. eCollection 2024 Aug. Open Forum Infect Dis. 2024. PMID: 39100532 Free PMC article.
Genetic Characterization and Population Structure of Drug-Resistant Mycobacterium tuberculosis Isolated from Brazilian Patients Using Whole-Genome Sequencing.
Esteves LS, Gomes LL, Brites D, Fandinho FCO, Bhering M, Pereira MADS, Conceição EC, Salvato R, Costa BPD, Medeiros RFM, Caldas PCS, Redner P, Dalcolmo MP, Eldholm V, Gagneux S, Rossetti ML, Kritski AL, Suffys PN. Esteves LS, et al. Among authors: kritski al. Antibiotics (Basel). 2024 May 28;13(6):496. doi: 10.3390/antibiotics13060496. Antibiotics (Basel). 2024. PMID: 38927163 Free PMC article.
189 results